Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more
Applied DNA Sciences, Inc. (BNBX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.300x
Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) has a cash flow conversion efficiency ratio of -0.300x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.55 Million) by net assets ($18.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Applied DNA Sciences, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Applied DNA Sciences, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Applied DNA Sciences, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mahalaxmi Rubtech Limited
NSE:MHLXMIRU
|
0.014x |
|
Dalaroo Metals Ltd
AU:DAL
|
-1.095x |
|
Ravinder Heights Limited
NSE:RVHL
|
0.004x |
|
Palash Securities Limited
NSE:PALASHSECU
|
-0.037x |
|
ICZOOM Group Inc. Class A Ordinary Shares
NASDAQ:IZM
|
0.083x |
|
Dom Maklerski IDM SA
WAR:IDM
|
0.421x |
|
Israel Land Development Company Co Ltd
TA:ILDC
|
0.013x |
|
UMS Holdings Bhd
KLSE:7137
|
0.018x |
Annual Cash Flow Conversion Efficiency for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Applied DNA Sciences, Inc. from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $1.94 Million | $-12.52 Million | -6.447x | -321.69% |
| 2024-09-30 | $8.97 Million | $-13.71 Million | -1.529x | -19.81% |
| 2023-09-30 | $4.87 Million | $-6.22 Million | -1.276x | -83.51% |
| 2022-09-30 | $12.91 Million | $-8.98 Million | -0.695x | +42.28% |
| 2021-09-30 | $11.11 Million | $-13.39 Million | -1.205x | -- |